Micro Pharmaceuticals
Market Cap
₹915 ₹915 Cr.
P/E
21.30
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Market cap
Market cap
915 Cr
PE
PE
21.30
Prom Holding
Prom Holding
43.02 %
ROE (%)
ROE (%)
51.51
ROCE (%)
ROCE (%)
28.63
Div Yield (%)
Div Yield (%)
-
Sales
Sales
652 Cr
OPM (%)
OPM (%)
15.10 %
Debt to Equity
Debt to Equity
3.37
Institutions
Institutions
0.95 %
Individual < 2 lac
Individual < 2 lac
20.76 %
No. of Shareholders
No. of Shareholders
17,174

About

Wanbury Limited, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 C… Read more
Low
162
52W Range
High
359
  • Wanbury
  • Bharat Parenterals
  • Anuh Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

Edit rows

Forensics

4 Yes

Positive for this company

1 Neutral

Neutral for this company

12 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Peer Comparison

FAQs on Wanbury Ltd. Business

Wanbury Limited is a prominent Indian pharmaceutical company ranked among the top 50 in the country. Specializing in API sales globally and domestic formulations, Wanbury has a significant presence in the industry.

Wanbury major competitors are Bharat Parenterals, Anuh Pharma, Kilitch Drugs(India), Zim Laboratories, Lincoln Pharma, Prevest Denpro, Jenburkt Pharma.
Market Cap of Wanbury is ₹915 Crs.
While the median market cap of its peers are ₹657 Crs.

Wanbury seems to be less financially stable compared to its competitors.
Altman Z score of Wanbury is 3.51 and is ranked 6 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Feb Jun Aug May Jun Nov Mar Jun Sep Dec Dec
Investor Presentation Feb Jul Nov
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material